Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6–12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms

Methylphenidate Preferentially Increases Catecholamine Neurotransmission within the Prefrontal Cortex at Low Doses that Enhance Cognitive Function

Craig W. Berridge, David M. Devilbiss, Matthew E. Andrzejewski et al. · Biological Psychiatry · 2006 · 626 citations

Life Sciences, Neuroscience, Pharmacology +17

Once-Daily Atomoxetine Treatment for Children and Adolescents With Attention Deficit Hyperactivity Disorder: A Randomized, Placebo-Controlled Study

David Michelson, Albert J. Allen, Joan Busner et al. · American Journal of Psychiatry · 2002 · 600 citations

Medicine, Pharmacology, Pharmacotherapy +17

Health-Related Quality of Life in Children and Adolescents Who Have a Diagnosis of Attention-Deficit/Hyperactivity Disorder

Anne F. Klassen, Anton R. Miller, Stuart Fine · PEDIATRICS · 2004 · 568 citations

Medicine, Child Health, Pediatrics +17

Once-Daily Atomoxetine Treatment for Children With Attention-Deficit/Hyperactivity Disorder, Including an Assessment of Evening and Morning Behavior: A Double-Blind, Placebo-Controlled Trial

Douglas K. Kelsey, Calvin R. Sumner, Charles D. Casat et al. · PEDIATRICS · 2004 · 467 citations

Medicine, Pharmacotherapy, Psychiatry +16

Driving-Related Risks and Outcomes of Attention Deficit Hyperactivity Disorder in Adolescents and Young Adults: A 3- to 5-Year Follow-up Survey

Russell A. Barkley, David C. Guevremont, Arthur D. Anastopoulos et al. · PEDIATRICS · 1993 · 397 citations

Medicine, Behavioral Sciences, Psychiatry +17